136 related articles for article (PubMed ID: 9576368)
1. The effect of a nitric oxide inhibitor (L-NAME) on peritoneal transport during dialysis in rats.
Breborowicz A; Wieczorowska-Tobis K; Korybalska K; Polubinska A; Radkowski M; Oreopoulos DG
Perit Dial Int; 1998; 18(2):188-92. PubMed ID: 9576368
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis.
Ferrier ML; Combet S; van Landschoot M; Stoenoiu MS; Cnops Y; Lameire N; Devuyst O
Kidney Int; 2001 Dec; 60(6):2343-50. PubMed ID: 11737609
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nitric oxide synthase reverses permeability changes in a mouse model of acute peritonitis.
Ni J; Cnops Y; McLoughlin RM; Topley N; Devuyst O
Perit Dial Int; 2005 Feb; 25 Suppl 3():S11-4. PubMed ID: 16048247
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide inhibition decreases neutrophil adhesion at the inflammatory site, while increasing adhesion in remote organs in peritonitis.
Fukatsu K; Saito H; Han I; Furukawa S; Hashiguchi Y; Lin MT; Matsuda T; Inaba T; Inoue T; Ikeda S; Yasuhara H; Muto T
J Surg Res; 1997 Feb; 68(1):79-86. PubMed ID: 9126199
[TBL] [Abstract][Full Text] [Related]
5. L-2-oxothiazolidine-4-carboxylate: an agent that modulates lipopolysaccharide-induced peritonitis in rats.
Korybalska K; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Moberly J; Martis L; Breborowicz A; Oreopoulos DG
Perit Dial Int; 2002; 22(3):293-300. PubMed ID: 12227385
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan modifies inflammatory response and peritoneal permeability during peritonitis in rats.
Breborowicz A; Polubinska A; Moberly J; Ogle K; Martis L; Oreopoulos D
Am J Kidney Dis; 2001 Mar; 37(3):594-600. PubMed ID: 11228185
[TBL] [Abstract][Full Text] [Related]
7. Dose effects of chronically infused nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester on anabolic response and arginine metabolism in rats with subacute peritonitis.
Hsiao CC; Lee CH; Tsao LY; Lo HC
Biol Pharm Bull; 2011; 34(2):177-82. PubMed ID: 21415524
[TBL] [Abstract][Full Text] [Related]
8. Substrate and inhibitor for nitric oxide synthase during peritoneal dialysis in rabbits.
Douma CE; Zweers MM; de Waart DR; van der Wardt AB; Krediet RT; Struijk DG
Perit Dial Int; 1999; 19 Suppl 2():S358-64. PubMed ID: 10406547
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal dialysis solution attenuates microvascular leukocyte adhesion induced by nitric oxide synthesis inhibition.
White R; Ram S
Adv Perit Dial; 1996; 12():53-6. PubMed ID: 8865873
[TBL] [Abstract][Full Text] [Related]
10. The Nitric Oxide Synthase Inhibitor NG-Nitro-L-Arginine Methyl Ester Diminishes the Immunomodulatory Effects of Parental Arginine in Rats with Subacute Peritonitis.
Lo HC; Hung CY; Huang FH; Su TC; Lee CH
PLoS One; 2016; 11(3):e0151973. PubMed ID: 27007815
[TBL] [Abstract][Full Text] [Related]
11. Peritoneal dialysis solutions reverse the hemodynamic effects of nitric oxide synthesis inhibitors.
White R; Barefield D; Ram S; Work J
Kidney Int; 1995 Dec; 48(6):1986-93. PubMed ID: 8587262
[TBL] [Abstract][Full Text] [Related]
12. The effect of the nitric oxide synthesis inhibitor L-NAME on amitriptyline-induced hypotension in rats.
Tuncok Y; Kalkan S; Murat N; Arkan F; Guven H; Aygoren O; Kurt S
J Toxicol Clin Toxicol; 2002; 40(2):121-7. PubMed ID: 12126183
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment of parenteral arginine and nitric oxide inhibitor N(G)-nitro-L-arginine methyl ester in rats with peritonitis.
Lee CH; Hsiao CC; Hung CY; Lo HC
J Surg Res; 2013 May; 181(1):99-105. PubMed ID: 22748943
[TBL] [Abstract][Full Text] [Related]
15. Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
Fang W; Mullan R; Shah H; Mujais S; Bargman JM; Oreopoulos DG
Perit Dial Int; 2008; 28(1):35-43. PubMed ID: 18178946
[TBL] [Abstract][Full Text] [Related]
16. Role of induced nitric oxide synthase and increased NO levels in zymosan peritonitis in the rat.
Boughton-Smith NK; Ghelani A
Inflamm Res; 1995 Aug; 44 Suppl 2():S149-50. PubMed ID: 8548372
[No Abstract] [Full Text] [Related]
17. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
Kim CK; Rivier C
J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
[TBL] [Abstract][Full Text] [Related]
18. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats.
PoĊubinska A; Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Chen C; Moberly JB; Martis L; Breborowicz A; Oreopoulos DG
Kidney Int; 2000 Mar; 57(3):1182-9. PubMed ID: 10720971
[TBL] [Abstract][Full Text] [Related]
19. [The effect of bacterial lipopolysaccharide on the gastric emptying of rats: a pretreatment evaluation using Nw-nitro-L-arginine methyl ester (L-NAME)].
Collares EF; Vinagre AM
Arq Gastroenterol; 2006; 43(3):229-32. PubMed ID: 17160240
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor in dialysate in relation to intensity of peritoneal inflammation.
Pawlaczyk K; Polubinska A; Numata N; Nakayama M; Pecoits-Filho R; Czekalski S; Lindholm B; Breborowicz A
Int J Artif Organs; 2008 Jun; 31(6):535-44. PubMed ID: 18609506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
